Kaplan-Meier estimate of PFS according to ctDNA status in patients with and without CR at C4D15. FL cohort with CR (A) and without CR (B); DLBCL cohort with CR (C) and without CR (D) in the C4D15 biomarker population, with PFS estimated from C4D15 response assessment date. Median PFS is presented in months.